BPC-157What the studies show

Q: What kind of evidence exists for BPC-157?

Animal and lab studies. Rat studies and cell studies, mostly from one research group, with no completed placebo-controlled trial in people. The mechanisms are plausible and repeatable in animals; the human evidence does not exist yet.

A 15-amino-acid piece of a stomach protein, studied for tendon, muscle and gut repair — almost entirely in rats.

5 min read · Animal and lab studies · Updated November 2026

In short

Name: BPC-157
Evidence: Animal and lab studies
Bottom line: Rat studies and cell studies, mostly from one research group, with no completed placebo-controlled trial in people. The mechanisms are plausible and repeatable in animals; the human evidence does not exist yet.

Before you read this

This guide explains what published studies found. That is all it is.

It is not medical advice and it is not instructions for using anything. Where a dose appears, we are reporting what a named study gave the people or animals in it — a fact about the study, not an instruction to you.

The compounds here are not approved by the FDA for use in people and are sold for laboratory research only. A study tells you what happened to the subjects in it; it does not tell you what would happen to you. Talk to a doctor first.

What it is

BPC-157 is a chain of 15 amino acids. It is a fragment of a larger protein that a research group in Zagreb reported finding in human gastric juice in the early 1990s, and the letters stand for "body protection compound" ¹. The same group has published most of what is known about it, and nearly all of that work is in rats. One thing that sets it apart from most peptides: in the lab it stayed intact in human gastric juice for more than 24 hours, where most peptides are broken down within minutes ¹.

The rest of this guide is free

Unlock the BPC-157 guide — and every other one

What the studies found, what they didn't, every source linked. Enter your email once; the link we send opens all of them on this device, plus one plain-language study breakdown a week.

Tendons and muscle

The best-known studies cut a rat's Achilles tendon and then watched it heal. In a 2003 study, rats given BPC-157 had tendons that were stronger and better organised at every time point measured than rats given saline, whether the peptide was injected or given by mouth ².

A 2011 study asked why. Tendon cells from rats were grown in a dish with BPC-157, and they grew outward from tendon explants faster, survived oxidative stress better, and migrated more readily into a scratch made in the cell layer ³. The authors tied this to a growth-factor pathway (FAK-paxillin) that cells use to move and attach.

Muscle has been studied the same way: crushed or cut rat muscle given the peptide recovered function sooner than untreated muscle in the Zagreb group's papers, which are summarised in their 2011 review ¹.

New blood vessels

A 2017 study from Taiwan looked at how BPC-157 might speed repair and found that it increased the growth of new blood vessels in rat tissue and in cultured endothelial cells (the cells that line vessels). The effect went through VEGFR2, the main receptor that tells those cells to multiply and form tubes ⁴. Blocking that receptor removed the effect, which is the kind of result that points at a real mechanism rather than a coincidence.

The gut

The peptide was found in stomach juice, and the gut is where the research started. In rats it protected the stomach lining from lesions caused by strong alcohol and by anti-inflammatory drugs, and it was studied for healing of the bowel after injury ¹. The same review lists dozens of rat models — ulcers, colitis, fistulas — most from one laboratory.

People

There is no completed, published, placebo-controlled trial of BPC-157 in people. A trial in ulcerative colitis was registered decades ago and its results were never published in full ¹. Everything above comes from animals or cells, and a rat tendon is not a human tendon.

In 2023 the U.S. Food and Drug Administration reviewed BPC-157 for its list of substances that pharmacies may compound and placed it in the category for substances that "may present significant safety risks", citing the lack of human safety data ⁵. That is a statement about what is unknown, not a finding of harm — and it is also why no one can honestly tell you what it does in a person.

What these studies are, and aren't

Animal and lab studies. Rat studies and cell studies, mostly from one research group, with no completed placebo-controlled trial in people. The mechanisms are plausible and repeatable in animals; the human evidence does not exist yet.